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Abstract
Background: Mutations in eukaryotic translation initiation factor 2B (eIF2B) cause Childhood Ataxia with CNS
Hypomyelination (CACH), also known as Vanishing White Matter disease (VWM), which is associated with a clinical
pathology of brain myelin loss upon physiological stress. eIF2B is the guanine nucleotide exchange factor (GEF) of eIF2,
which delivers the initiator tRNA
Met to the ribosome. We recently reported that a R132H mutation in the catalytic subunit of
this GEF, causing a 20% reduction in its activity, leads under normal conditions to delayed brain development in a mouse
model for CACH/VWM. To further explore the effect of the mutation on global gene expression in the brain, we conducted a
wide-scale transcriptome analysis of the first three critical postnatal weeks.
Methodology/Principal Findings: Genome-wide mRNA expression of wild-type and mutant mice was profiled at postnatal
(P) days 1, 18 and 21 to reflect the early proliferative stage prior to white matter establishment (P1) and the peak of
oligodendrocye differentiation and myelin synthesis (P18 and P21). At each developmental stage, between 441 and 818
genes were differentially expressed in the mutant brain with minimal overlap, generating unique time point-specific gene
expression signatures.
Conclusions: The current study demonstrates that a point mutation in eIF2B, a key translation initiation factor, has a massive
effect on global gene expression in the brain. The overall changes in expression patterns reflect multiple layers of indirect
effects that accumulate as the brain develops and matures. The differentially expressed genes seem to reflect delayed waves
of gene expression as well as an adaptation process to cope with hypersensitivity to cellular stress.
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Introduction
Childhood Ataxia with Central nervous system Hypomyelina-
tion (CACH), also known as Vanishing White Matter disease
(VWM), is an autosomal recessive genetic leukodystrophy
associated with mutations in any one of the five subunits of
eukaryotic translation initiation factor 2B (eIF2B) [1,2]. The
classical form of CACH/VWM is manifested during early
childhood as progressive motor and cognitive impairments that
ultimately lead to death by adolescence. Onset of signs and
symptoms usually follows exposure to various environmental
stressors, such as febrile illness, minor head trauma and acute
fright, which also lead to exacerbation of symptoms during the
course of disease progression. The diagnosis of CACH/VWM is
based on MRI scans showing decreased brain white matter signals.
The disease predominantly affects oligodendrocytes and astro-
cytes, while neurons are relatively preserved [3–9]. An R136H
mutation in the human EIF2B5 gene, encoding the catalytic
subunit of eIF2B, is known to cause the classical form of CACH/
VWM when present in a homozygous state. We recently
generated a mutant mouse model for CACH/VWM disease by
introducing an R132H mutation into the mouse EIf2b5 gene locus,
which corresponds to the R136H mutation in the human gene.
The mutant mice exhibit delayed development of brain white
matter, higher proportion of small-caliber nerve fibers, abnormal
abundance of oligodendrocytes and astrocytes, specifically in
young animals, and abnormal levels of major myelin proteins.
Moreover, the mutant mice failed to recover from cuprizone-
induced demyelination, reflecting an increased sensitivity to brain
insults and difficulty in repairing damaged myelin [10].
eIF2B is the guanine nucleotide exchange factor (GEF) of
translation initiation factor eIF2, which in its GTP-bound form
binds aminoacylated initiator methionyl-tRNA to form the eIF2-
GTP-tRNAi
Met ternary complex. The formation of ternary
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GDP-eIF2 back to its active GTP-eIF2 form following release
from the ribosome at each round of translation initiation [11,12].
eIF2B serves as a central regulatory hub governing global protein
synthesis rates by responding to forms of cellular stress including
starvation, viral infection, heat shock, accumulation of unfolded
proteins in the ER, changes in intracellular calcium levels and
oxidative stress, which activate one of four kinases that
phosphorylate the a-subunit of eIF2 [13]. Phosphorylated eIF2
is a strong competitive inhibitor of eIF2B; given that eIF2B is
significantly less abundant than eIF2, low levels of phosphorylated
eIF2 are sufficient to effectively inhibit eIF2B activity, resulting in
a significant decrease in global translation [14,15].
Our previous results indicating abnormal brain development of
the Eif2b5-mutated mice urged us to further explore the molecular
mechanism responsible for the delayed white matter formation
during the first three critical postnatal weeks. For this purpose, we
conducted a genome-wide transcriptome analysis at three early
postnatal stages of wild-type and mutant mice homozygous for the
Eif2b5 R132H mutation. The data reveal a massive effect of the
point mutation in EIf2b5 on global gene expression in the brain
and provide a plausible explanation of the severity of CACH/
VWM disease, despite the ‘‘mere’’ 20% reduction in eIF2B
enzymatic activity associated with this specific mutation [10]. The
largely disjoint differential gene expression signatures at the
different time points suggest that EIf2b5 mutation may lead to
delayed brain development [10] by delaying waves of gene
expression. The overall changes in gene expression patterns in the
mutant mice may reflect multiple layers of indirect effects that
accumulate as the brain develops and matures. This is most
probably the result of a slight decrease in the translation efficiency
of mRNAs that encode key regulators, e.g., transcription factors,
components of the RNA processing machinery, and RNA binding
proteins that affect mRNA stability. The identity of these
regulatory factors, and how their expression level affect the fine
tuning of brain development, is yet to be identified.
Results
A point mutation in Eif2b5 affects the expression of
distinct sets of genes at different developmental stages
In a previous study, we reported that the R132H mutation in
the catalytic subunit of translation initiation factor 2B (eIF2B5)
leads to delayed brain development in a mouse model for CACH/
VWM disease [10]. To identify mutation-induced changes in
overall gene expression in the mouse brain, we performed whole
genome microarray analyses at different time points during the
first three weeks of postnatal mouse brain development. Postnatal
days 1, 18 and 21 were chosen to reflect early development prior
to white matter establishment (P1) and the peak of oligodendrocye
differentiation and myelin synthesis (P18 and P21) [16,17]. For
each time point, total RNA was isolated from the entire brain
excluding the cerebellum of 3 wild-type and 3 mutant mice,
followed by genome-wide measurement of mRNA expression by
Affymetrix microarray (Mouse Genome 1.0 ST). At each time
point, between 441 and 818 genes were differentially expressed in
the eIf2b5 R132H mutant mice (fold-change .1.2; t-test p,0.05,
Figure 1A and File S1). There was surprisingly little overlap
between the sets of genes dysregulated at different time points
(Figure 1B). The differential expression of a total of 7
representative genes was validated by qRT-PCR (Figure 1C).
The unique time-point-specific differential gene expression
signature suggests that the altered global protein synthesis in
mutant mice elicits a unique response depending on the
developmental stage of the brain.
Expression of cell-cycle related genes is low in mutant
mice during early postnatal brain development
Each set of differentially-expressed genes was analyzed for
enrichment of gene sets known to share a common function or
gene sets previously reported to share common expression patterns
during mouse development (see Materials and Methods; Table 1
and File S2 for complete enrichment results). Interestingly, the
gene set differentially expressed at P1 was enriched with genes
related to cell-cycle progression, whereas the gene set differentially
expressed at P21 was enriched with oligodendrocyte-specific
genes. Of the 44 cell-cycle associated genes the expression of
which was low in the mutant brain at P1, 11 were related to
mitosis (Table 1). During early postnatal stages, brain cells
undergo multiple divisions [18]. Thus, lower expression level of
mitotic genes may adversely affect cell proliferation during this
critical developmental stage. This is consistent with the recently-
reported delayed brain development of Eif2b5-mice [10]. Inter-
estingly, during normal mice brain development (in Mus musculus
WSB/EiJ strain), all 44 cell-cycle associated genes are highly
expressed immediately after birth (P0) and down-regulated
thereafter (Figure 2A, data extracted from GEO series
GSE11528 [19], t-test p=4.4?10
226). A similar trend was
observed in the current study using wild-type (C57BL strain)
mice, in which these specific genes were highly expressed at P1
and then down-regulated at P18 and P21 (Figure 2B, white bars
[19], t-test p=2.2?10
227). However, in mutant mice, the
expression level of each of these genes was significantly lower at
P1 (p,0.05), indicating that Eif2b5 mutation either suppresses the
up-regulation of cell-cycle associated genes immediately after birth
or induces their premature down-regulation at P1 instead of at a
later time point (Figure 2B, black bars). The lower level of two
mRNAs, cyclin A2 and cyclin B1, was further validated by qRT-
PCR (Figure 1C, grey bars). Since both cyclin A2 and cyclin B1
are required for progression through mitosis, their decreased
expression level is expected to prolong mitosis [20]. To assess the
progression of Eif2b5-mutated cells through the cell cycle, primary
astrocytes were isolated from the brains of wild type and mutant
newborn (P1) mice and subjected to flow cytometry analysis
following propidium iodide staining of their DNA. It is expected
that for a non-immortalized culture, the percentage of dividing
cells will decline while the length of their G1 phase will increase,
with time. Therefore, we expected to see more cells in G1/G0 and
fewer cells in G2/M, as the cell culture gets older. This is indeed
what was observed, for both WT and mutated primary astrocytes.
However, at all time points tested, the FACS analysis demon-
strated that significantly higher proportion of Eif2b5-mutated
primary astrocytes were in G2/M phase (on the expense of the G1
phase, data not shown) compared to the WT cells. This indicates
that the G2/M phase is significantly prolonged due to the
mutation in Eif2b5 (Figure 2C).
Oligodendrocyte-specific genes are repressed in mutant
mice during the peak of myelin formation
Comparison of our data with expression dataset from neuronal
cell types (GSE9566, [21], clustered using CLICK [22]) revealed a
highly-significant overlap between the genes repressed in Eif2b5-
mutated mice at P21 and genes that are highly expressed in
oligodendrocytes (see Materials and Methods and Figure 3A,
p=1.06?10
231). The latter set of genes was also enriched in genes
with decreased expression level at P18, but to a lesser extent
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Eif2b5 negatively affects specific oligodendrocyte functions at
postnatal days 18 and 21, considered the peak period of myelin
formation [16,17]. We focused on 52 genes of the oligodendro-
cyte-specific cluster with lower expression level at P21 in the
mutants. During normal brain development of mice (in Mus
musculus WSB/EiJ strain), the expression level of these genes is low
immediately after birth (P0), increases by P14 and remains high at
P56 (data extracted from GEO series GSE11528 [19]; see
Figure 3B, t-test P=7.5?10
256 for the difference between P0
and P14). A similar trend was observed with our wild-type mice,
which exhibited a relatively low expression level of these genes at
P1 followed by up-regulation by P18 and P21 (Figure 3C, white
bars, t-test p=5.6?10
267 for the difference between day 1 and day
18). However, in contrast to wilt-type mice, the expression level of
each of these genes in Eif2b5-mutated mice was significantly lower
at P21 (p,0.05), indicating abnormal down-regulation at this
time-point (Figure 3C, black bars). This pattern is consistent with
the delayed brain development associated with the point mutation
in Eif2b5, as reported earlier [10].
Temporal dynamics of differential expression in the
mutant mouse brain
Next, we selected 39 genes for further validation by qRT-PCR,
focusing on postnatal days P3 and P21 (Table 2). Of the 39 genes,
the change in expression of 20 genes was validated (Table 2, bold)
and these were divided into three groups based on their expression
pattern (Figure 4A). Group I consists of 12 genes that were down
regulated in the mutant mice at P3 (Figure 4A, black triangles) but
normally expressed at P21 (Figure 4A, white squares). This group
includes two translation initiation factors (Eif4g and Eif2b5), a
major myelin protein 29,39-Cyclic-nucleotide 39-phosphodiesterase
Figure 1. Differential gene expression at three postnatal time points. RNA extracted from the entire brain (cerebellum excluded) of wild-
type and mutated mice at P1, P18 or P21 was analyzed for whole genome mRNA expression level by Affymetrix microarrays. File S1 lists all the
differentially expressed genes. (A) Heatmap of relative gene expression in mutant mice when compared to wild type. For each mutant mouse, the
expression level relative to the average of the three WT mice is shown. For visualization purposes, only genes exhibiting fold-change .1.35 (p,0.05)
are shown. Red indicates higher expression in the mutant and blue indicates higher expression in the wild type. The dendogram shows a hierarchical
clustering of the expression levels of all the genes using average linkage. (B) The number of genes that are differentially expressed at two different
time points (fold-change .1.2; p,0.05). ‘up’ and ‘down’ refer to elevated or lower expression level, respectively, in the mutant relative to the wild-
type mice at each time point. (C) Validation of selected differentially expressed genes. For validation, RNA was extracted from additional brains of
wild-type and mutant mice at each developmental time point. Ratio of mRNA levels [log2(mutant/wild-type)] of the specific indicated genes
determined by Affymetrix microarrays is shown (black) alongside with its level as detected by qRT-PCR and calculated relative to GAPDH control
(gray). The qRT-PCR data represents the average of 3 biological samples (p,0.05).
doi:10.1371/journal.pone.0026992.g001
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(Apoe, Ldlr, Scd1). Group II consists of 4 genes that were up-
regulated in the mutant mice at P21 (Figure 4A, black squares); of
these, 2 (Aqp4 and Col1a1) were normally expressed at P3
(Figure 4A, white triangles) while Col1a2 was down-regulated
and Dusp1 (also known as Mkp1) was up-regulated at P3 (Figure 4A,
black triangles). Group III consists of Comt1, Hspa12a, Hyou1 and
Ppp1r15b (also known as Crep), all of which were down-regulated in
the mutant mice both at P3 and P21 (Figure 4A, black squares and
triangles). In order to dissect differential expression on a finer
temporal scale, we selected 2 genes for further analysis, namely
Catechol-O-methyltransferase 1 (Comt1) and Dual specificity
protein phosphatase 1 (Dusp1/Mkp1), which were either down-
regulated (Comt1) or up-regulated (Dusp1/Mkp1) at both P3 and
P21 (Figure 4A). We monitored Comt1 and Dusp1/MPK1
mRNA levels in the brain of wild-type and mutant mice by
qRT-PCR at several postnatal timepoints from P1 to P60.
Interestingly, whereas no difference in Comt1 mRNA levels was
observed between wild-type and mutant mice at P1, Comt1
mRNA level in mutant mice was down-regulated soon after birth
(at P3) and remained lower compared to wild-type mice for at least
3 weeks (P7, P14 and P21), followed by normal levels in adult
mutant mice (P60) (Figure 4B). This underlines the transient
abnormality of Comt1 gene expression during early postnatal
brain development due to Eif2b5 mutation. Analysis of Dusp1/
Mkp1 mRNA levels also showed transient mutation-induced
differences. Importantly, our analysis revealed that during normal
brain development, Dusp1/Mkp1 expression is down-regulated in
the first week after birth followed by gradual up-regulation in the
second and third weeks until it returns to its initial high levels in
the adult brain (Figure 4C, white squares). Dusp1/Mkp1 mRNA
levels were similar in wild-type and Eif2b5-mutated mice during
the first two postnatal weeks. However, while Dusp1/Mpk1
mRNA levels increased in a moderate fashion during the third
postnatal week in the wild-type mice, its levels ascended more
drastically in the mutant mice, building abnormal up-regulation
specifically during the peak of white matter formation (Figure 4C,
black squares).
Spatial dynamics of differential expression in mutant
mice brain
To better understand the spatial distribution of abnormal gene
expression, 12 genes were selected for further analysis of mRNA
levels in the cerebrum and brain-stem of wild-type and Eif2b5-
mutated mice at P21. The expression level of 2 of these genes
(Cend1, Gjc2) was altered only in the brain stem but not the
cerebrum, whereas the expression level of others (Aqp4, Cola1,
Cola2, Dusp1/Mkp1 and Ppp1r15b/Crep) was altered only in the
Table 1. Enrichments of co-annotated genes among the differentially expressed genes.
Total no. Enrichment category No. genes p-value
P1 Up regulated genes: 406 Localization: Dendrite 17 2.94?10
25
Neuronal genes (GSE9566) 35 5.63?10
26
Blood circulation 6 1.00?10
23
Down regulated genes: 412 Localization: chromosome 28 2.40?10
28
Cell cycle 44 3.72?10
211




P18 Up regulated genes: 209 P16 and P26 neuronal genes (GSE9566) 14 8.90?10
29
Retinal binding 3 2.04?10
26
Positive regulation of T cell differentiation 3 0.007
Down regulated genes: 232 Localization: Intracellular organelle 126 1.11?10
26
Glial cell migration 2 0.004
P21 Up regulated genes: 235 Neuronal genes (GSE9566) 26 1.02?10
25
Astrocytes genes (GSE9566) 27 3.84?10
27
Innate immune response 18 1.59?10
24
Down regulated genes: 279 Localization: extracellular region 34 1.18?10
27
Mixed oligodendroglia genes (GSE13379) 55 2.97?10
221
Oligodendrocytes genes (GSE9566) 52 1.04?10
231
Astrocytes genes (GSE9566) 29 1.18?10
26
Astrocytes genes (GSE13379) 19 1.19?10
27
Iron ion binding 17 1.87?10
26
Oxidoreductase activity 11 1.32?10
26
Sterol metabolism 14 1.96?10
211
Axon ensheathment 7 5.91?10
26
Differentially expressed gene sets were compared to Gene Ontology biological process annotations [50] and KEGG pathway annotations [51] using the hypergeometric
distribution and corrected for multiple testing using the Benjamini and Hochberg FDR method [52]. They were also compared to two brain cell type-specific gene
expression datasets [21,53] which refer to GEO accessions GSE9566 and GSE13379. For each dataset, we first clustered the gene expression patterns using CLICK [22],
manually annotated each cluster based on each expression pattern; and then tested the significance of the overlap between each set of differentially expressed genes
in our data and each co-expression cluster using the hypergeometric test. Full gene lists of enrichment results are presented in File S2.
doi:10.1371/journal.pone.0026992.t001
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of yet another group of genes (Comt1, Hspa12a and Hyou1) was
altered in both brain regions (Table 3). Of these, Comt1 was down-
regulated in both regions while Hspa12a and Hyou12 were up-
regulated in the brain stem but down-regulated in the cerebrum at
P21 (Table 3). To test if Hspa12a and Hyou12 also share similar
age-specific alterations, their mRNA levels were quantitated by
qRT-PCR at P3 in both brain regions. This analysis revealed that
at both time points during early postnatal development, the
mutation in Eif2b5 led to lower levels of Hspa12a and Hyou1
mRNAs in the cerebrum (as indicated by the higher DCt values,
Figure 5) and higher levels of both mRNAs in the brain stem (as
indicated by the lower DCt values, Figure 5).
Discussion
Brain development is the result of coordinated interactions
between molecular networks and systematic cross-talk between
certain cell types influencing the development of others via waves
of transcription/translation of specific genes. During development,
the brain undergoes typical stages involving proliferation,
differentiation, myelination, synapse formation, and maturation
of synaptic function [18,23–25]. Research into the underlying
molecular mechanisms led to a series of gene profiling studies
revealing that during development, gene expression profiles
undergo spatial and temporal changes that correlate with
phenotypic functions [19,26–29]. The study of Wen et al. [30]
demonstrated that fundamental patterns of temporal fluctuations
in gene expression during development can be determined even
without the dissection of whole tissues into distinct anatomical sub-
regions. Here we studied a mutant mouse homozygous for a point
mutation in the catalytic subunit of the translation initiation factor
eIF2B, which leads to a ,20% decrease in its enzymatic activity.
This mutant mouse is the first animal model for eIF2B-related
leukodystrophy (also termed CACH/VWM disease). The disease
in humans is manifested as impaired white matter functions, which
deteriorate upon stress conditions to loss of axonal function,
followed by death [5–7]. We recently demonstrated that the
Eif2b5-mutated mice suffered from delayed brain development
under normal conditions, a circumstance not associated before
with human patients probably since it can only be detected in the
pre-symptomatic stage [10]. The current study further demon-
strates the profound effect of the seemingly-superficial impairment
in eIF2B activity on the entire gene expression profile throughout
early postnatal brain development. Both wild-type and mutant
mice underwent similar changes in global gene expression, which
underlie CNS transition from a primarily proliferative state during
the first postnatal week to a highly differentiated state later on.
However, the expression of cell-cycle associated genes at P1 and
white matter-specific genes at P21 were significantly dysregulated
in mutant compared to wild-type mice (Figures 2B, 3C). The
unique time-point-specific differential gene expression signature
(Figure 1, Table 1) together with the delayed brain development
observed in Eif2b5-mutated mice [10], suggests that the mutation
in eIf2b5 is responsible for delayed waves of gene expression,
resulting in prolonged development. The delay is not uniform
across the transcriptome, but seems to affect specific subset of
genes. This can be the result of a slight decrease in translation
efficiency of mRNAs that encode key regulators e.g. specific
transcription factors, RNA processing machinery components
and/or RNA binding proteins that affect the steady-state level of a
subset of gene products.
Figure 2. Expression of cell cycle-related genes. Average expression patterns of the 44 cell cycle-related genes with lower expression level in
mutant mice at P1 (see Materials and Methods). (A) Expression during normal mouse brain development according to the measurements in [19].(B)
Expression according to the current study. The expression pattern of each gene was normalized to mean=0 and standard deviation=1. The average
expression of the genes in all replicates is shown for each time point. Error bars represent one standard error. (C) Primary astrocytes were isolated
from wild-type (WT) and mutant (mut) mice brains at P1. Following 4, 8 and 24 days in culture, the cells were subjected to flow cytometry analysis
using propidium iodide for DNA staining. The precentage of cells in G2/M phase is shown for wild-type (WT, white) and mutant (mut, black) primary
astrocytes, representing the average of 3 independent experiments. t-test p values are indicated.
doi:10.1371/journal.pone.0026992.g002
eIF2B-Mutated Brain Transcriptome
PLoS ONE | www.plosone.org 5 October 2011 | Volume 6 | Issue 10 | e26992Obviously, the overall difference in gene expression patterns in
the mutant mice may reflect multiple layers of indirect effects that
accumulate as the brain develops and matures. The delayed wave
of gliogenesis-specific gene expression beyond postnatal day 21
and the inexact steady-state levels of mRNAs within the wave is in
agreement with the abnormal time-course MRI of the mutants.
More specifically, while the fractional anisotropy parameter
seemed to be pseudo-normalized at an older age, the abnormal
diffusion coefficient parameter was indicative of tissue pathology
[10]. Indeed, defective glial maturation was also found in the
brains of CACH/VWM human patients [9,31]. Interestingly,
translation initiation factors (e.g. eIf2b5, eIf4g1) and multiple genes
involved in lipid and cholesterol metabolism, as well as myelin
formation (e.g. Ldlr, Apoe, Scd1, Syt2, Cnp, Vim), were down-
regulated at P3 but not at P21 (Figure 4A, Table 2, File S2)
emphasizing the outcome of early perturbation of gene expression
on the whole-brain phenotype at a later stage despite pseudo-
normalization of expression of certain genes at older ages. The
transient differential expression of Comt1 serves as an additional
example for the delayed white matter development. Comt1, an
abundant protein in astrocytic processes surrounding synapses
[32], is responsible for metabolizing catecholamine neurotrans-
mitters following their uptake by glial cells (known as the less
important uptake route, termed uptake2) [33]). The transient
down-regulation of Comt1 in the mutant brain during early
postnatal development (Figure 4B) is in agreement with the
delayed differentiation of astrocytes observed in the mutants [10]
and coincides with the defective generation of astrocytes in
CACH/VWM human patients [9,31].
Another set of differentially-expressed genes relates to stress
response. Among these are Hspa12a, Hyou1, Ddit3, Ppp1r15b/Crep,
Dusp1/MKP1 and others (Figure 4A, Table 2, and File S2). It is of
note that CACH/VWM disease is strongly associated with stress:
(a) myelin loss and associated neurological symptoms of human
patients deteriorate upon exposure to various stressors [4,5,6,34];
(b) the unfolded protein response (UPR) pathway was found to be
activated in the brains of CACH/VWM patients [35,36]; (c)
primary cultured fibroblasts isolated from CACH/VWM patients,
as well as oligodendroglia derived-cell line expressing mutated
eIF2B, are hypersensitive to induced ER stress [37,38]; and (d)
Figure 3. Expression of oligodendtocyte-related genes. Differential expression of the 52 genes with lower expression level in mutant mice at
P21 that are also co-expressed in oligodendrocytes according to GEO accession GSE9566 [21] (see Materials and Methods). The expression pattern of
each gene was normalized to mean=0 and standard deviation=1. (A) The average expression pattern of these genes in various brain cell types at
various developmental time points as measured in [21]. (B) The average expression pattern of these genes during normal mouse brain development
as measured in [19]. (C) The average expression pattern of these genes according to the current study. Error bars show one standard error.
doi:10.1371/journal.pone.0026992.g003
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[10]. It is widely accepted that myelination is a stressful
endogenous process, as differentiation of oligodendrocyte precur-
sor cells to mature myelinating oligodendrocytes involves synthesis
of large amounts of lipids and proteins, accompanied by UPR
activation to reduce the high rate of protein misfolding.
Unbalanced expression of UPR-related genes prevents efficient
differentiation and may lead to apoptosis or mal-differentiation.
Since mutations in eIF2B lead to hypersensitivity to stress,
malfunctioning of the myelination process is not surprising and
expected to reflect the net result of all adaptive mechanisms. In
this respect, it is interesting to note that Ppp1r15b/Crep is down-
Table 2. Temporal dynamics of differential gene expression.
P3 P21
Gene symbol RQ PV RQ PV Gene Bank
Abca1 0.90 0.20 0.95 0.09 NM_013454.3
Adamts9 1.11 0.68 1.10 0.64 NM_175314.3
Adm 0.78 0.24 1.14 0.76 NM_009627
Apoe 0.64 0.04 0.95 0.69 NM_009696.3
Aqp4 0.96 0.66 1.62 0.00 NM_009700.2
Ccl21a 1.05 0.48 0.97 0.64 NM_011335.2, NM_011124.4, NM_023052.2
Cend1 0.94 0.12 1.00 0.99 NM_021316.3
Cldn11 1.03 0.54 1.04 0.79 NM_008770.2
Cnp 0.56 0.02 0.98 0.89 NM_009923.1
Col1a1 0.92 0.19 1.67 0.05 NM_007742.3
Col1a2 0.74 0.01 1.43 0.05 NM_007743.2
Comt1 0.79 0.00 0.78 0.00 NM_007744.3, NM_001111062.1 NM_001111063.1
Ddit3 0.83 0.03 1.03 0.63 NM_007837.3
Ddr2 0.97 0.82 1.14 0.31 NM_022563.2
Dusp1 1.26 0.03 1.77 0.02 NM_013642.3
Eif2ak2 1.21 0.14 0.97 0.80 NM_011163.4
Eif2b5 0.72 0.02 0.88 0.35 NM_172265
Eif4g1 0.83 0.02 1.09 0.28 NM_001005331.1 NM_145941.2
Ermn 0.95 0.67 1.23 0.15 NM_029972.3
Fasn 0.81 0.14 0.99 0.88 NM_007988.3
Gjc2 1.08 0.90 1.12 0.61 NM_080454.4 NM_175452.4
Gpm6a 0.88 0.22 0.86 0.16 NM_153581.3
Hhip 1.06 0.75 0.95 0.63 NM_020259.4
Hspa12a 0.72 0.00 0.75 0.02 NM_175199.3
Hyou1 0.73 0.00 0.88 0.03 NM_021395.3
Lcat 0.84 0.26 1.20 0.17 NM_008490.1
Ldlr 0.63 0.01 1.12 0.38 NM_010700
Mag 0.86 0.82 1.05 0.75 NM_010758.2
Mobp 1.09 0.92 1.09 0.36 NM_001039365.2 NM_008614.2
Ndn 0.71 0.03 1.18 0.17 NM_010882.3
Notch3 0.81 0.19 1.04 0.55 NM_008716
P4ha1 0.76 0.01 0.94 0.46 NM_011030.2
Plxnb3 0.78 0.12 0.96 0.75 NM_019587.2
Ppp1r15b 0.66 0.00 0.75 0.05 NM_133819.2
Scd1 0.85 0.02 1.15 0.43 NM_009127.4
Stab1 0.83 0.26 1.20 0.08 NM_138672.2
Syt2 0.73 0.03 1.09 0.60 NM_009307.3
Trf 0.73 0.03 1.32 0.16 NM_133977.2
Vim 0.69 0.02 0.92 0.49 NM_011701.3
RNA from cerebrum of wild-type and mutant mice at P3 and P21 was isolated and analyzed by qRT-PCR using specific primers. RQ=relative quantification of averaged 3
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Table 2). Ppp1r15b/Crep promotes dephosphorylation of the
translation initiation factor eIF2a to enable efficient protein
synthesis [39]. Therefore, this down-regulation of Ppp1r15b/Crep
in the brain may suggest a process of adaptation to prolong UPR
length in order to allow sufficient differentiation rates. To support
proper protein folding, increased chaperone activity is also
required. Indeed, expression of Hspa12a and Hyou1 is up-
regulated at both P3 and P21 in the mutant brain (Figure 4A).
Both are members of the Hsp70 chaperone family, induced by
thermal or oxidative stress to protect the cells from ER stress-
induced apoptosis [40–42].
In rodents, the process of myelination in the CNS occurs
essentially after birth, proceeds along a caudo-rostral axis, and is
completed by the third postnatal week. During development,
mature oligodendrocytes expressing markers such as myelin basic
protein (MBP) accumulate first in the spinal cord and then in the
diencephalon, the brainstem, the cerebellum, and finally the
cerebral hemispheres [43]. Notably, Hspa12a and Hyou1
expression in the mutants is up-regulated in the brain stem but
not in the cerebrum (Figure 5), which is most probably in
synchrony with the level of gliogenesis and myelination in this
white matter-rich sub-anatomical region. It is unclear why
Hspa12a and Hyou1 expression is down-regulated in the
cerebrum at both ages in the mutant compared to wild-type mice
(Figure 5), but this may be of clinical significance as CACH/
VWM symptoms are localized to the cerebrum, while the
brainstem is preserved. Interestingly, Hspa12a also shows reduced
expression in the prefrontal cortex of subjects with schizophrenia
[44]. An additional notable differential expression in the mutant
brain is that of Dusp1/Mkp1, which dephosphorylates threonine
and tyrosine residues of MAP kinases and inhibits MAPK
signaling [45]. It was recently shown that the intensity and
duration of JNK signaling are essential determinants of cellular
response to ER stress in neurons and neuronal stem cells. Whereas
transient JNK activation is a protective event, prolonged JNK
activation mediates pro-apoptotic signaling. Moreover, Li and co-
workers demonstrated that JNK activation is tightly controlled in
these cells through ER stress-mediated Dusp1/Mkp1 activation
[46]. Here we found that Dusp1/Mkp1 expression level is
gradually decreased in both wild-type and mutant brains from
postnatal day 1 to day 7, followed by gradual increase as the brain
develops towards adulthood. Strikingly however, the increased
level during the second and third postnatal weeks is significantly
higher in mutant mice (Figure 4C), suggesting that Eif2b5-mutated
brains are forced to employ extra protective means during stressful
periods such as times of differentiation, synaptogenesis and
massive myelination.
The current study reveals the massive effect of a mild point
mutation in eIF2B, a key translation initiation factor, on global
gene expression in the brain. It provides a plausible explanation of
the severity of CACH/VWM disease, despite the ‘‘mere’’ 20%
reduction in eIF2B enzymatic activity associated with this
mutation. Future experiments using system biology approaches
will enable the discovery of the molecular circuits involved in this
pathology and may provide the basis for rational drug design.
Figure 4. qRT-PCR of selected genes during development. RNA was isolated from the entire brain excluding the cerebellum of wild-type (WT)
and mutant (mut) mice at different postnatal stages as indicated, and tested for specific mRNAs level by qRT-PCR using specific primers. Each mRNA
expression level is the average of 3 biological samples calculated relative to GAPDH control. (A) P3, triangles; P21, squares. p,0.05, black; p.0.05,
white. See Table 2 for exact p values of all samples. (B) Relative quantity of Comt1 mRNA level in mut relative to WT mice at P1, P3, P7, P14, P21 and
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Mice maintenance and sample collection
For all testing, we used male wild-type and mutant siblings of
heterozygote mice that were backcrossed to the C57BL strain. All
experimental procedures involving mice were approved by the Tel
Aviv University Animal Care Committee according to national
guidelines (permit #L-09-35). Pups at different ages as indicated
were collected from WT or Eif2b5-mutated mating cages, housed
in an animal facility with a 14/10 h light/dark cycle in filtered-top
cages supplemented with autoclaved wood chips in laminar flow
hoods. Animals were fed autoclavable rodent pellet (Koffolk 19–
510, Koffolk Ltd, Petach Tikva, Israel) and sterile water ad libitum
throughout the experiments. Mice were decapitated followed by
brain removal, separation to cerebrum, brain stem and cerebellum
when needed and flash freezing in liquid nitrogen for further use.
For all experiments, each sample represents the brain of a single
mouse.
Genotyping and sex determination
DNA was isolated from mice tails using GenElute Mammalian
Genomic DNA Miniprep Kit (Sigma) and used for genotyping by
PCR as described previously [10]. Newborn mice were tested for
their sex by PCR using specific primers for SRY on the Y
chromosome (SRY-Fwd 59TCTTAAACTCTGAAGAAGA-
GAC39 and SRY-rev 59GTCTTGCCTGTATGTGATGG39)
and for NDS on the X chromosomes (NDS-Fwd 59 GAGTGCC-
TCATCTATACTTACAG39 and NDS-rev 59TCTAGTT-
CATTGTTGAGTTGC39) [47].
RNA isolation
Total RNA from brain tissues was isolated using Trizol reagent
(Invitrogen). RNA samples for microarray analysis were further
cleaned using Phase Lock Gel (Eppendorf). RNA quality was
assessed by its absorbance at 260 nm and 280 nm using a
NanoDrop spectrophotometer and its integrity was assessed by
agarose gel electrophoresis.
Microarray and data analysis
The GeneChip Mouse Gene 1.0ST Array (Affymetrix, Santa
Clara, CA), which interrogates 28,853 mouse genes across 770,317
distinct probes, was used for expression profiling. A single chip was
used to profile the expression pattern of a single brain. A total of
18 chips were used (three WT and three mutant brains were used
for each of three time points). Affymetrix GeneChip Whole
Transcript Sense Target Labeling Assay Manual Version 4 was
followed for generation and amplification of biotinylaed sense-
strand DNA targets. Briefly, 300 ng total RNA underwent first-
strand and second strand cDNA synthesis. Complementary RNA
was generated and used to produce sense-strand cDNA, which was
fragmented and end-labeled with biotin. Microarrays were
hybridized, washed, stained, and scanned according to the
protocol described in the WT sense target labeling assay manual
Figure 5. qRT-PCR of Hspa12a and Hyou1 in different brain
regions. RNA was isolated from the cerebrum or brain stem of wild
type (WT) and mutated (mut) mice at P3 and P21 followed by qRT-PCR
analysis using primers specific for Hspa12a (A) and Hyou1 (B). Each
mRNA expression level shown is the average of 3 biological samples
calculated relative to GAPDH control. Data are presented as DCt (gene
of interest/GAPDH). High DCt value indicates low mRNA level. The
calculated relative quantity (RQ) in mut relative to WT is shown for each
case; * indicates p,0.05.
doi:10.1371/journal.pone.0026992.g005
Table 3. Spatial dynamics of differential gene expression at
P21.
Cerebrum Brain stem
Gene symbol RQ pv RQ pv Gene Bank
Cend1 1.00 0.99 0.82 0.03 NM_021316.3
Gjc2 1.12 0.61 1.66 0.02 NM_080454.4
Ldlr 1.12 0.38 1.49 0.06 NM_175452.4
NM_010700
Trf 1.32 0.16 1.52 0.06 NM_133977.2
Aqp4 1.62 0.00 1.47 0.07 NM_009700.2
Col1a1 1.67 0.05 0.99 0.92 NM_007742.3
Col1a2 1.43 0.05 1.14 0.25 NM_007743.2
Dusp1 1.77 0.02 0.96 0.70 NM_013642.3
Ppp1r15b 0.75 0.05 1.12 0.30 NM_133819.2
Comt1 0.78 0.00 0.70 0.00 NM_007744.3,
NM_001111062.1
NM_001111063.1
Hspa12a 0.75 0.02 1.5 0.00 NM_175199.3
Hyou1 0.88 0.03 1.34 0.03 NM_021395.3
RNA from cerebrum of wild-type and mutated mice at P21 was isolated and
analyzed by qRT-PCR using specific primers. RQ=relative quantification of
averaged 3 biological samples calculated relative to GAPDH control. Data is
presented as expression level in mutant relative to wild-type mice. PV, p value;
Bold indicates a significant change (p,0.05).
doi:10.1371/journal.pone.0026992.t003
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normalized using RMA [48]. Probes were mapped to Entrez Gene
identifiers using BioMart [49]. Genes were defined as differentially
expressed if the ratio between the average expression in three
mutant and the three WT mice was at least 1.2 and t-test p-value
was below 0.05. For visualization purposes (Figures 2 and 3), the
expression pattern of each gene was normalized to mean=0 and
standard deviation=1. All original data files from the microarray
experiments have been deposited in the National Center for
Biotechnology Information Gene Expression Omnibus (GEO,
accession number GSE32201). File S1 contains all the differen-
tially expressed genes (p,0.05). All data is MIAME compliant.
Functional analysis of the differentially expressed genes
Differentially expressed gene sets were compared to Gene
Ontology biological process annotations [50] and KEGG pathway
annotations [51] using the hypergeometric distribution and
corrected for multiple testing using the Benjamini and Hochberg
FDR method [52]. In order to test if the differentially expressed
genes were preferentially expressed in specific brain cell types, we
also analyzed two brain cell type-specific gene expression datasets
[21,53] which refer to GEO accessions GSE9566 and GSE13379,
respectively]. For each dataset, we first clustered the gene
expression patterns using CLICK [22], manually annotated each
cluster based on each expression pattern; and then tested the
significance of the overlap between each set of differentially
expressed genes in our data and each co-expression cluster using
the hypergeometric test. Full gene lists of enrichment results
(Table 1) are presented in File S2.
cDNA preparation and quantitative real-time PCR
Following RNA isolation, RNA samples were further purified
using DNase I (QIAGEN) to remove potential genomic DNA
contamination, when TaqManH PCR reactions were performed.
For syber-green qRT-PCR, 1 mg of RNA was reversed-transcribed
using Verso cDNA kit (Thermo scientific). qRT-PCR was carried
out for 40 cycles in a Rotor-Gene 6000 (Corbett research) using
primers for cyclin-B1 (cycB1-Fwd 59CAGAGTTCTGAACTT-
CAGCCTG39 and cycB1-rev 59TTGTGAGGCCACAGTT-
CACCAT39); cyclin-A2 (cycA2 Fwd 59TGAGTTTGATA-
GATGCTGACCCG39 and cycA2-rev 59 ATCCAGTCTGTTG-
TGCCAATGAC39); Serpina3n (ser3n-Fwd 59GGGAAGTCTT-
CTCCACACAGG39 and ser3n-rev 59AATTTGACTCCAGTG-
GCAGCA39); Comt1 (com-Fwd 59GCTACTCAGCCGTGC-
GAATGG39 and com-rev 59 GCCACATTCCTCCAGGA-
GAAGTG39); RPL34 (rpl34-Fwd 59 AGAAGGTTGGGAAAG-
CACCT39 and rpl34-rev 59ATAAGGAAAGCCCGCTTGA-
T39); and GAPDH which was used an internal control
(GAPDH-Fwd 59TGGCAAAGTGGAGATTGTTGCC39 and
GAPDH-rev 59AAGATGGTGATGGGCTTCCCG39). For Taq-
ManH PCR reactions, 1 mg of RNA was converted to cDNA using
the High-Capacity cDNA Reverse Transcription Kit (Agentek,
Applied Biosystems). qRT-PCR was carried out for 40 cycles in a
StepOne Real-time PCR system (Applied Biosystems) using gene-
specific TaqManH Gene Expression Assay (Agentek, Applied
Biosystems). We used TaqManH for hspa12a (Mm00558341_m1),
dusp1 (Mm00457274_g1), hyou1 (Mm00491279_m1), aqp4
(Mm00802131_m1), eIF4G1 (Mm00524099_m1) and GAPDH
(Mm99999915_g1) as control. Additional genes were tested using
TaqMan Low Density Array (TLDA, Applied Biosystems) using
ABI Prism PCR - HT7900 (Applied Biosystems).
see Table 2.
Primary astrocytes isolation and cell cycle analysis
Primary astrocytes were derived and grown as previously
described [54]. For Cell cycle assay, primary astrocytes cells were
collected by centrifugation and resuspended in 0.5 ml phosphate
buffered saline (PBS) containing 0.1 mg/ml of propidium Iodide
(Sigma Cat # P4170) and 0.1% sodium azid. propidium Iodide
fluorescence was detected on 5000 cells and determined by
fluorescence-activated cell sorting (FACS) analysis (FACSort; BD
Biosciences, USA). Quantification of cell cycle phases was
analyzed by CellQuest software (BD Biosciences).
Supporting Information
File S1 Complete data of whole genome analyses of
RNA isolated from the entire brain, excluding the
cerebellum, of 3 wild type and 3 Eif2b5-mutant mice at
postnatal days 1, 18 and 21 using Affymetrix Mouse
Genome 1.0 ST microarrays. RNA from each mouse was
analyzed on a separate chip. The differentially expressed genes for
each developmental time point (P1, P18 and P21) are presented.
(XLS)
File S2 Full gene lists of enrichment results of the
differentially expressed gene sets.
(XLS)
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